15.1.2025 14:01:01 CET | Thor Medical ASA | Meldepliktig handel for primærinnsidere
Oslo, Norway, 15 January 2025: Ekornhuset AS, a close associate of chairperson of the board of Thor Medical ASA, Ludvik Sandnes, has today acquired 200,000 shares in Thor Medical ASA at a price of NOK 2.491 per share.
Primary insider notifications pursuant to the market abuse regulation article 19 are attached.
This information is subject to disclosure requirements pursuant to the EU Market Abuse Regulation article 5 and the Norwegian Securities Trading Act section 5-12.
Kontakter
Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com
Om Thor Medical ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
To learn more, visit www.thormedical.no.
Vedlegg
Last ned som PDF.pdf
20250115 – MAR Form – Ekornhuset AS.pdf
